Skip to content
lifestyle.mmminimal.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Medicus Pharma Ltd
Medicus Pharma to Present at BIO-Europe 2026
November 5, 2026
Medicus Pharma to Host Third Quarter 2026 Financial Performance and Business Update Call on November 9, 2026
November 4, 2026
Medicus Pharma Announces Proposed SkinJect® Business Combination and Concurrent Financing
November 4, 2026
Medicus Pharma to Present at BioFuture and Global Biotechnology Summit
October 27, 2026
Medicus Pharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
October 26, 2026
Medicus Pharma Highlights Three Years of Progress and Outlines Potential Path to Long Term Value
October 8, 2026
Medicus Pharma Submits Optimized Teverelix® Registrational Protocol to FDA to Create Partner Ready Program in Advanced Prostate Cancer
September 29, 2026
Medicus Pharma Announces Exclusive Development Focus for SkinJect® in Gorlin Syndrome Following Commercial, Clinical and Regulatory Assessment
September 21, 2026
Medicus Pharma Publishes Abridged Final Phase 2 SkinJect® Clinical Study Report (CSR) Results Identifying 200 µg D-MNA Patch as the Lead Development Dose
September 10, 2026
Medicus Pharma Focuses on Precision Oncology and CD228V
September 8, 2026
1
2
3
Next Page
→